Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected Meningiomas
International Journal of Radiation Oncology*Biology*Physics · 2025-05 · 122 (1) · 150-158
DOI: 10.1016/j.ijrobp.2024.12.003 ↗Kurz gefasst
Leitlinie in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2025-05. Verfasst von Haley K Perlow und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, Ohio. Hauptthemen laut MEDLINE: Meningeal Neoplasms, Meningioma, Organometallic Compounds, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Mayo Clinic, The Ohio State University Comprehensive Cancer Center Arthur G James Cancer Hospital and Richard J Solove Research Institute.
Abstract (Originalsprache)
PURPOSE: Meningiomas are the most common primary intracranial tumor. Somatostatin receptor 2 is almost universally expressed in meningioma tissue. For patients who require adjuvant radiation, somatostatin receptor based (68)Ga-DOTATATE positron emission tomography (PET) imaging can detect additional or residual disease not discernible on magnetic resonance imaging. PET guided radiation treatments may improve local control, minimize toxicity by allowing for more precise radiation therapy plans, and allow for more precise dose-escalation to maximize local control. The aim of this study was to develop consensus PET guided treatment planning guidelines for common meningioma presentations. METHODS AND MATERIALS: Five postoperative clinically relevant meningioma cases were selected from a prospective single-institutional registry of patients. Each patient had a preoperative and postoperative contrast-enhanced T1-weighted volumetric magnetic resonance imaging, and a postoperative (68)Ga-DOTATATE PET/CT, to assist with target delineation. The full treatment scenario including clinical history, histology, surgical history, and imaging were provided for each patient. Nineteen international experts who have published on the treatment and management of meningiomas, and who use (68)Ga-DOTATATE PET/CT in their practice, evaluated each case. Individual prescription recommendations were created, pooled, and discussed to create consensus recommendations. RESULTS: Consensus recommendations were created for each case. In most cases, PET-based contouring allowed for more precise dose-escalation to 66-70 Gy targeting residual disease. When compared to RTOG 0539 and modern clinical trial contouring guidelines, a smaller clinical target volume expansion from the surgical cavity was recommended using PET guided radiation plans in the absence of radiographic or pathologic evidence of brain or bone invasion. CONCLUSIONS: This report provides consensus target volume delineation guidelines for meningiomas receiving postoperative radiation in common clinical situations. Integration of these guidelines into clinical practice may allow for more precise biomarker guided radiation treatments and standardize radiation therapy on future meningioma clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, Ohio.
- Departments of Radiation Oncology, Neurological Surgery, and Pathology, University of California, San Francisco, California.
- Department of Radiation Oncology, Columbia University Vagelos College of Physicians and Surgeons and New York-Presbyterian, New York, New York.
- Department of Radiation Oncology, Stanford University, Stanford, California.
- Department of Radiation Oncology, University of Rochester Medical Center, Wilmot Cancer Institute, Rochester, New York.
- Department of Radiation Oncology, Mayo Clinic Rochester, Rochester, Minnesota.
Förderung
- Mayo Clinic
- The Ohio State University Comprehensive Cancer Center Arthur G James Cancer Hospital and Richard J Solove Research Institute
Zitieren
APA
Perlow, H. K., Raleigh, D. R., Wang, T. J. C., Pollom, E. L., Milano, M. T., Breen, W. G., Detsky, J., Chang, E. L., Tom, M. C., Shiue, K. R., Lehrer, E. J., Saeed, H., Pike, L. R. G., Lo, S. S., Mishra, M. V., Knisely, J. P. S., Chao, S. T., Sahgal, A., & Palmer, J. D. (2025). Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected Meningiomas. International Journal of Radiation Oncology*Biology*Physics, 122(1), 150-158. https://doi.org/10.1016/j.ijrobp.2024.12.003
Vancouver
Perlow HK, Raleigh DR, Wang TJC, Pollom EL, Milano MT, Breen WG, et al. Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected Meningiomas. International Journal of Radiation Oncology*Biology*Physics. 2025;122(1):150-158. doi:10.1016/j.ijrobp.2024.12.003
BibTeX
@article{Perlow2025,
author = {Perlow, Haley K and Raleigh, David R and Wang, Tony J C and Pollom, Erqi L and Milano, Michael T and Breen, William G and Detsky, Jay and Chang, Eric L and Tom, Martin C and Shiue, Kevin R and Lehrer, Eric J and Saeed, Hina and Pike, Luke R G and Lo, Simon S and Mishra, Mark V and Knisely, Jonathan P S and Chao, Samuel T and Sahgal, Arjun and Palmer, Joshua D},
title = {Consensus Radiation Treatment Planning Guidelines Using (68)Ga-DOTATATE PET/CT For Resected Meningiomas},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2025},
volume = {122},
number = {1},
pages = {150--158},
doi = {10.1016/j.ijrobp.2024.12.003}
}
EUVIMED